FDA Inspection
OpAns, LLCOpAns, LLC – FDA Inspection, Aug 16, 2019
Record Details
This FDA Inspection record concerns OpAns, LLC, with an inspection on August 16, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · ffc11075-1841-44fb-a1e4-8350073d633b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1102873
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
Other FDA inspections of OpAns, LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| January 24, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 24, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 3, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 18, 2008 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for OpAns, LLC
- FDA Inspection 1230774 - 2024-01-24
- FDA Inspection 1125999 - 2020-01-24
- FDA Inspection 937288 - 2015-08-03
- FDA Inspection 547289 - 2008-11-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.